JSW
MEDP icon

Journey Strategic Wealth’s Medpace MEDP Stock Holding History

Journey Strategic Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Sell
823
-119
-13% -$60.9K 0.01% 422
2025
Q4 		$529K Buy
942
+58
+7% +$32.9K 0.01% 300
2025
Q3 		$455K Buy
884
+158
+22% +$69K 0.01% 324
2025
Q2 		$228K Buy
+726
New +$218K 0.01% 555
2025
Q1 		– Sell
-659
Closed -$219K – 531
2024
Q4 		$219K Buy
659
+28
+4% +$9.5K 0.01% 438
2024
Q3 		$211K Buy
631
+7
+1% +$2.66K 0.01% 459
2024
Q2 		$257K Buy
624
+23
+4% +$9.11K 0.01% 293
2024
Q1 		$243K Buy
+601
New +$211K 0.01% 233

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Journey Strategic Wealth's MEDP Position: Q1 2026 in Review

Journey Strategic Wealth reduced its Medpace (MEDP) stake by 13% in Q1 2026, selling an estimated $60.9K and leaving 823 shares worth $395K. The position accounts for 0.01% of the portfolio, ranked #422.

Journey Strategic Wealth first reported a position in MEDP in Q1 2024 and has held it in 8 quarters since. The position peaked at $529K in Q4 2025. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Journey Strategic Wealth held 823 shares of Medpace worth $395K as of Q1 2026.
  • Journey Strategic Wealth sold 119 Medpace shares in Q1 2026, an estimated $60.9K.
  • Medpace made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #422 holding.
  • Journey Strategic Wealth first reported a position in Medpace in Q1 2024 and has held it in 8 quarters since.
  • Journey Strategic Wealth's Medpace position peaked at $529K in Q4 2025.
  • 733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.